Intrinsic Value of S&P & Nasdaq Contact Us

Petros Pharmaceuticals, Inc. PTPI NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
13/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Petros Pharmaceuticals, Inc. (PTPI) has 9 known insider and institutional holders on record. The largest holder is Silverman Joshua with 4,415,450 shares. Other notable holders include Bernstein Bruce and Boctor Fady.

Over the last 12 months, insiders have made 4 transactions in PTPI stock — 4 buys (valued at RSU Award) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

PTPI Insider Ownership

Top Holder
Silverman Joshua
4,415,450 shares
Buys (12 mo)
4
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 100%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Silverman Joshua Director 4,415,450 2026-01-02
100%
2 Bernstein Bruce Director 1,887,334 2026-01-02
43%
3 Boctor Fady See Remarks 519,986 2026-01-06
12%
4 Walker Wayne Remell Director 506,333 2026-01-02
11%
5 Arnold Mitchell See Remarks 150,000 2025-02-21
3%
6 Shulman John D 10 Percent Owner 109,329 2022-01-03
2%
7 Gesek Andrew President, Timm Medical 75,000 2021-08-05
2%
8 Bradley Greg Director 40,000 2023-12-26
1%
9 Lavan Keith Chief Financial Officer 975 2020-12-03
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-01-02 Boctor Fady See Remarks RSU Award 500,000 - -
2026-01-02 Bernstein Bruce Director RSU Award 1,875,000 - -
2026-01-02 Silverman Joshua Director RSU Award 4,375,000 - -
2026-01-02 Walker Wayne Remell Director RSU Award 500,000 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message